M&A Deal Summary

PBI Acquires Uncle Bud s

On January 11, 2024, PBI acquired consumer products company Uncle Bud s

Acquisition Highlights
  • This is PBI’s 1st transaction in the Consumer Products sector.
  • This is PBI’s 2nd transaction in the United States.
  • This is PBI’s 1st transaction in California.

M&A Deal Summary

Date 2024-01-11
Target Uncle Bud s
Sector Consumer Products
Buyer(s) PBI
Deal Type Add-on Acquisition

Target

Uncle Bud s

Beverly Hills, California, United States
Uncle Bud's is a producer and retailer of hemp and CBD products for pain relief, skincare, personal care, and pet care. Uncle Bud’s was formed in 2018 and is based in Beverly Hills, California.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PBI

Canton, Massachusetts, United States

Category Company
Founded 1978
Sector Medical Products
Employees15
Revenue 2M USD (2022)
DESCRIPTION

PBI engages in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Pressure BioSciences, Inc. products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBI was founded in 1978 and is based in South Easton, Massachusetts.


DEAL STATS #
Overall 2 of 2
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-29 CannaWorx

Ridgefield, New Jersey, United States

CannaWorx, Inc. has developed an extensive portfolio of consumer products, which include FDA cleared, patented/ patent pending diverse products that capitalize on disruptive delivery systems in the areas of pain relief, pharmaceuticals, skincare, nutraceuticals, and agricultural/veterinary products.

Buy -